Stockreport

Vanda Pharma: High Risk, Heavily Discounted - Stock Ahead Of PDUFA This Week [Seeking Alpha]

Vanda Pharmaceuticals Inc.  (VNDA) 
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm Check Earnings Report
PDF VNDA's valuation is deeply discounted, trading at 1.4x forward sales and 0.5x EV/sales, reflecting high regulatory and execution risk. Upcoming catalysts include the [Read more]